Abstract Details
|
J. Theodore Phillips, MD, PhD, FAAN
PRESENTER |
No disclosure on file |
| April A. Erwin, MD (Rocky Mountain Multiple Sclerosis Clinic) | Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Erwin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol-Myers Squibb. The institution of Dr. Erwin has received research support from Genentech. The institution of Dr. Erwin has received research support from Abbvie. The institution of Dr. Erwin has received research support from Novartis. The institution of Dr. Erwin has received research support from Biogen. |
| No disclosure on file | |
| Marcelo C. Kremenchutzky, MD, FAAN (Lhsc - UWO) | No disclosure on file |
| John F. Kramer, BA, PA-C | Mr. Kramer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Mr. Kramer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Mr. Kramer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Mr. Kramer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Mr. Kramer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Mr. Kramer has received research support from Biogen. Mr. Kramer has received research support from Genentech. |
| Jonathan A. Kendter, PharmD (Biogen Idec) | No disclosure on file |
| Heather Abourjaily, PharmD | No disclosure on file |
| Jitesh Rana, MD, MBBS | No disclosure on file |
| Robert J. Fox, MD, FAAN (Cleveland Clinic) | Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care. |
| Tanuja Chitnis, MD, FAAN (Brigham and Women's Hospital) | Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover. |